Atrial specific potassium channels as new drug targets in atrial fibrillation

Atrial specific potassium channels as new drug targets in atrial fibrillation - blockers of IKAch and IK,Ca

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29754

Enrollment

Registered

2006-08-18

Start date

2007-01-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: nvt

Exclusion criteria

Exclusion criteria: nvt

Design outcomes

Primary

Measure	Time frame
Contractile forces and action potentials will be measured in human atrial muscle bundles. In addition, contraction, electrophysiological properties and changes in the intracellular calcium concentration will be measured in isolated cardiomyocytes.	—

Countries

Netherlands

Outcome results